Signal2026-07-02
ClinicalTrials.gov

[PHASE4] Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects

Part of

Assay Interpretation And Biomarker Guidelines

Open primary sourceSee the whole picture